Home LiteratureArticle Details
PMID: 1702807 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 146 ·No. 2 ·1991-01-15 ·Pages 592-8

Thornhill MH, Wellicome SM, Mahiouz DL, Lanchbury JS, Kyan-Aung U, Haskard DO

Abstract

The adhesion of lymphocytes to vascular endothelium is the first step in their passage from the blood into inflammatory tissues. By modulating endothelial cell (EC) adhesiveness for lymphocytes, cytokines may regulate lymphocyte accumulation and hence the nature and progression of inflammatory responses. IL-1, TNF, IFN-gamma, and IL-4 each increase EC adhesiveness for T cells when used alone in adhesion assays in vitro. As cytokines are more likely to act in combination at sites of inflammation in vivo, we have studied the stimulating effect of different combinations of cytokines on EC adhesiveness for T cells and polymorphonuclear leukocytes (PMN). Acting alone IL-1, TNF, IFN-gamma, and IL-4 each significantly enhanced EC adhesiveness for T cells (p less than 0.005), whereas only IL-1 (p less than 0.005) and TNF (p less than 0.005) but not IFN-gamma or IL-4 significantly enhanced adhesiveness for PMN. When EC were stimulated with optimal concentrations of TNF in combination with IL-4 or IFN-gamma, there was a significant further increase in adhesiveness for T cells (p less than 0.003), but not PMN, over that seen with TNF alone. The additive effect of TNF and IL-4 was more marked than that of TNF and IFN-gamma. Although approximately equal proportions of T cells and PMN bound to TNF-stimulated EC, nearly double the proportion of T cells compared with PMN bound EC preincubated with TNF and IL-4 together. A similar interaction with IL-4 or IFN-gamma was exhibited by lymphotoxin. mAb-inhibition studies indicated that the extra increase in binding caused by stimulating EC with TNF and IL-4 in combination was mediated by VCAM-1 whereas that caused by stimulating with TNF and IFN-gamma in combination was substantially mediated through leukocyte function-associated Ag-1- and VCAM-1-independent mechanisms. These observations suggest that whereas IL-1 and TNF alone are unselective in terms of leukocyte adhesion to EC, the combination of TNF (or LT) with IL-4 or IFN-gamma may be of key importance in determining the recruitment of a lymphocyte-predominant infiltrate in immune mediated inflammation, and in initiating the transition from acute to chronic inflammation.

MeSH Terms
Antibodies, Monoclonal Antigens, CD/physiology CD18 Antigens Cell Adhesion/physiology Cell Adhesion Molecules/physiology Endothelium, Vascular/physiology Humans In Vitro Techniques Interferon-gamma/physiology Interleukin-4/physiology Neutrophils/physiology Receptors, Leukocyte-Adhesion/physiology T-Lymphocytes/physiology Tumor Necrosis Factor-alpha/physiology Vascular Cell Adhesion Molecule-1
Chemicals
Antibodies, Monoclonal Antigens, CD CD18 Antigens Cell Adhesion Molecules Receptors, Leukocyte-Adhesion Tumor Necrosis Factor-alpha Vascular Cell Adhesion Molecule-1 Interleukin-4 Interferon-gamma
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Thornhill M H
Division of Medicine, United Medical School, Guy's Hospital, London, England.
Wellicome S M
Mahiouz D L
Lanchbury J S
Kyan-Aung U
Haskard D O
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1991-01-15
Pages
592-8
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
Wellcome Trust · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com